Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1260699

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1260699

Multiplex Assay Market: Current Analysis and Forecast (2022-2028)

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

The Multiplex Assay Market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Multiplex assay is a type of biological assay that allows simultaneous measurement of multiple analytes (such as proteins, nucleic acids, or metabolites) in a single sample. This technique has gained increasing popularity in the field of biotechnology and biomedical research due to its ability to provide comprehensive information on multiple biomolecules at once. The growing demand for multiplex assay can be attributed to the expanding need for research and development in the fields of molecular diagnostics and companion diagnostics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in response to the COVID-19 outbreak, Thermo Fisher Scientific developed a multiplex real-time PCR diagnostic kit (TaqPath COVID-19 Multiplex Diagnostic Solution) to facilitate public and clinical health laboratories to rapidly diagnose SARS-CoV-2 infection.

Based on the technology, the multiplex assay market is segmented into multiplex real-time PCR, flow cytometry, and others. The multiplex real-time PCR segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR technologies for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into clinical diagnostics and research & development. The research & development segment grabbed a considerable market share during the forecast period. Multiplex assays are becoming more and more used in the drug discovery process. These tests are employed in preclinical and clinical phases to assess drug response biomarkers, immunotherapy efficacy, and toxicity.

For a better understanding of the market adoption of multiplex assay, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the multiplex assay industry owing to the presence of various research programs in the region, as well as the expansion of R&D efforts for the creation of new medications and diagnostic and therapeutic approaches. The rise in government financing for the discovery of new biomarkers and the increased frequency of chronic diseases like cancer and stroke are expected to fuel the region's growth. Furthermore, the rise is probably going to be fueled by the presence of important players in the area.

Some of the major players operating in Luminex Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Seegene Inc., Perkin Elmer Inc., Abcam PLC, Agilent Technologies Inc. among others. Several M&A's along with partnerships have been undertaken by these players.

Product Code: UMHE211736

TABLE OF CONTENTS

1MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Multiplex Assay Market
  • 2.2. Research Methodology of the Multiplex Assay Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET

6 MULTIPLEX ASSAY MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Reagents & Consumables
  • 7.2. Instruments & Accessories
  • 7.3. Software & Services

8 MARKET INSIGHTS BY TYPE

  • 8.1. Protein-Based Multiplex Assay
  • 8.2. Nucleic Acid-Based Multiplex Assay
  • 8.3. Others

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1. Multiplex Real-Time PCR
  • 9.2. Flow Cytometry
  • 9.3. Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Clinical Diagnostics
  • 10.2 Research & Development

11 MARKET INSIGHTS BY END-USER

  • 11.1. Pharmaceutical & Biotechnology Companies
  • 11.2. Hospitals & Diagnostic laboratories
  • 11.3. Research & Academic Institutes
  • 11.4. Others

12 MARKET INSIGHTS BY REGION

  • 12.1 NORTH AMERICA
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 EUROPE
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Spain
    • 12.2.5 Italy
    • 12.2.6 Rest of Europe
  • 12.3 ASIA PACIFIC
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 Rest of Asia Pacific
  • 12.4 REST OF THE WORLD

13 MULTIPLEX ASSAY MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 MULTIPLEX ASSAY MARKET OPPORTUNITIES

15 MULTIPLEX ASSAY MARKET TRENDS

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1 Demand Side Analysis
  • 16.2 Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

  • 20.1. Qiagen NV
  • 20.2. New England Biolabs
  • 20.3. Illumina, Inc.
  • 20.4. Bio-Rad Laboratories, Inc.
  • 20.5. BGI Genomics Co Ltd
  • 20.6. Oxford Nanopore Technologies PLC
  • 20.7. PerkinElmer, Inc.
  • 20.8. Becton Dickinson and Co
  • 20.9. Bayer AG
  • 20.10. Agilent Technologies Inc

21 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!